Skip to content

Nexstim NBT software 2

by Nexstim Oyj

Nexstim NBT software 2 is a stereotactic neuronavigation/planning system (FDA Class II) made by Nexstim Oyj, listed in FDA GUDID since 28 Dec 2017 (UDI-DI 06430063200156), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number06430063200156 UDI-DI Date28 Dec 2017ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
NBT main software
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Nexstim NBT software
Generic name
Stereotactic neuronavigation/planning system
Model / reference
2
Primary DI / UDI-DI
06430063200156
FDA product code
GWF, IKN, HAW, OBP
GMDN term
Stereotactic neuronavigation/planning system
Device class
Class II
Regulation number
882.1870, 890.1375, 882.4560, 882.5805
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GWF (Stimulator, Electrical, Evoked Response).

Other devices from Nexstim Oyj

See all devices from Nexstim Oyj →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)